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Background: Emergence of a novel swine-origin influenza A (H1N1) pandemic since 2009 attracted the attention of scientists to 
characterize epidemiological features and clinical manifestations of this disease in comparison to seasonal flu in different parts of the 
world.
Objectives: The goal of this investigation was to compare these features in confirmed cases of swine-origin influenza A (H1N1) and seasonal 
flu in the 2009 epidemic in Qazvin province, Iran.
Patients and Methods: This cross sectional study was performed during 2009 in the Qazvin province. The epidemiological characteristics 
and clinical manifestations of all cases with severe flu-like manifestations were registered. Diagnosis of confirmed cases of both groups 
was performed by Real Time-Polymerase Chain Reaction (RT-PCR) on respiratory secretions of positive cases of swine-origin influenza A 
(H1N1) and seasonal influenza that were entered in the study. Analysis of quantitative data was performed using paired t-test and those of 
qualitative variables by chi square and Fisher’s exact test.
Results: Among a total of 518 patients with clinical signs of severe influenza throughout the Qazvin province, 76 confirmed cases of swine-
origin influenza A (H1N1) and 36 cases of other types of influenza A (seasonal influenza) were detected. The mean age of the first group 
was 25.67 ± 16.9 years and that of the second group was 36.03 ± 19.8, with a significant difference between the two groups (P < 0.01). The 
appearance of diarrhea was significantly higher in patients with swine-origin influenza compared to those with seasonal influenza (P < 
0.005). There was no statistically significant difference in the number of hospitalizations, need for intensive care, assisted ventilation, and 
mortality rate between the two groups.
Conclusions: Higher prevalence of disease in younger individuals, higher rate of gastrointestinal manifestations and occurrence outside 
of the epidemic season, were the most important characteristics of swine-origin influenza in comparison to seasonal influenza, in the 
2009 pandemic of Qazvin province, Iran.
Keywords: Influenza A Virus, H1N1 Subtype; Epidemiology
Copyright © 2015, School of Paramedical Sciences, Qazvin University of Medical Sciences. This is an open-access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-
rial just in noncommercial usages, provided the original work is properly cited.
1. Background
Epidemiological features and clinical symptoms of sea-
sonal influenza have been thoroughly studied and well 
known for many years. Epidemics of influenza within the 
recent years have caused numerous absences from work 
and even death worldwide. The majority of severe cases of 
disease and mortalities occur in old people and the second-
ary bacterial pneumonia is regarded as the major cause 
of death (1). Within the past few years, repeated antigenic 
drifts have occurred in seasonal influenza viruses leading 
to outbreaks of disease every three to four years. However, 
no obvious change in epidemiological features and clini-
cal manifestations of the disease was reported. During the 
spring of 2009, numerous cases of influenza outside the flu 
season and mostly with different epidemiological features, 
especially higher incidence and more severe cases amongst 
the younger age group were described. The etiological 
agent was a new influenza virus, which was named as the 
swine origin novel influenza A (H1N1) virus (SO-IV) because 
of its antigenic similarity to North American swine flu vi-
ruses. Following the identification of the genetic content 
of this virus, it became evident that the genomic content 
was different from all other viruses isolated from human 
and animals so far (2). Later, it became evident that the new 
virus had emerged through reassortment of two swine vi-
ruses, a human virus, and an avian virus yet with a genome 
mostly originated from the swine virus. The first confirmed 
case of the disease in the Qazvin province was reported dur-
ing July 2009 followed by another 76 confirmed cases of 
disease throughout the province. 
2. Objectives
Considering the international reaction towards the 
emergence of this pandemic and the epidemiological di-
versities between novel and seasonal influenza, and also 
extensive global concentration on symptoms of disease, 
the present study focused on comparing the epidemio-
Bijani B et al.
Biotech Health Sci. 2015;2(2):e262162
logical features, clinical manifestations, and the final out-
come of the swine-origin influenza A (H1N1) compared 
with seasonal influenza in the Qazvin province. Our 
research is the only study so far, comparing confirmed 
cases of seasonal influenza with swine-origin influenza A 
(H1N1) in the Eastern Mediterranean region.
3. Patients and Methods
3.1. Study Design 
This was a descriptive cross-sectional study carried out 
between July and December 2009 in the province of Qa-
zvin (Iran). Data were collected through the national in-
fluenza follow-up program carried out by the Ministry of 
Health and Medical Education in cooperation with the 
universities of medical sciences throughout the country 
(3). Sampling of respiratory secretions was performed for 
patients with clinical manifestations of severe influenza, 
who had visited the health centers within the province 
during this period. A confirmed case of influenza was 
defined as a patient with fever, moderate to severe respi-
ratory symptoms, and positive RT-PCR test performed 
on respiratory secretions. Demographic characteristics, 
epidemiological features, clinical manifestations, and 
the course and outcome of the disease were recorded in 
patient surveillance forms by health officers and medical 
staff of the health centers and referral hospitals. 
3.2. Laboratory Analysis
Samples were inoculated into Dulbecco’s modified Ea-
gle’s medium and transferred to the molecular division 
of the province’s reference laboratory and kept at 70°C 
until DNA extraction. Laboratory diagnosis of etiological 
agents was accomplished by the Real Time-Polymerase 
Chain Reaction (RT-PCR) technique using one and two-
stage commercial PCR kits (Qiagen, Germany and Invi-
trogen, Brazil) and application of three sets of primers; 
specific probes for universal influenza A virus, swine 
influenza A virus, and swine H1N1 virus, according to 
the World Health Organization (WHO) instructions (4). 
The specimens that produced a positive reaction with 
all three sets of primers were considered as having the 
swine-origin influenza A (H1N1) virus and those with no 
polymerization reaction with all three primers were re-
garded as negative. The virus strains that only produced 
a positive reaction with the universal influenza A primer 
were considered as the seasonal influenza virus.
3.3. Statistical Analysis 
Data were analyzed by Epi info ™ version 3.5.1 software us-
ing paired t-test, chi square and Fisher’s exact test. P values 
less than 0.05 were considered statistically significant. 
4. Results
Between July and December 2009, out of 518 tested pa-
tients, 76 confirmed cases of swine-origin influenza A 
(H1N1) and 36 confirmed cases of infection with other types 
of influenza A viruses (seasonal flu) were detected. Ten hos-
pitals in five cities within the province were in charge of 
providing inpatient facilities to the patients. The incidence 
of disease during different months is shown in Figure 1. 
The age range of patients with pandemic influenza was 
between two months and 72 years with a median age of 23 
years and mean age of 25.67 ± 16.9 years, while in those with 
seasonal influenza the age range, median age, and mean 
age were one month to 80 years, 30 years, and 36.03 ± 19.8 
years, respectively. The difference in mean age of patients 
with pandemic influenza and those with seasonal influen-
za was statistically significant (P = 0.005). Table 1 presents 
information on the studied subjects, including age, gen-
der, contact with similar patients, and traveling abroad. As 
shown by Table 1, age below 18 years and contact with simi-
lar patients are risk factors of pandemic influenza through 
univariate analysis, whereas none of these parameters 
were demonstrated to have any statistically significant cor-
relation with a diagnosis of seasonal influenza. Table 2 il-
lustrates a comparison of the incidence rate of major clini-
cal manifestations of disease (fever, cough, body aches and 
diarrhea) between pandemic and seasonal influenza. As in-
dicated by Table 2, the only significant difference between 
pandemic and seasonal influenza was the higher preva-
lence of gastrointestinal symptoms whereas no significant 
difference was found between the two groups associated 
with fever, cough and muscular pain. 
Among 112 patients with confirmed diagnosis of influ-
enza, 62 cases with pandemic and 32 with seasonal influ-
enza were hospitalized. Of the hospitalized patients with 
pandemic influenza, twelve cases were admitted to Inten-
sive Care Units (ICUs) and eleven needed mechanical ven-
tilation while two patients died because of the severity of 
disease. The number of admissions to ICUs for confirmed 
cases of seasonal flu was seven patients amongst which, 
five needed assisted ventilation and eventually one pa-
tient failed to recover from the disease. As shown in Table 
3, no significant difference concerning these variables 
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Figure 1. The Epidemiological Curve of Confirmed Cases of Swine-Origin 
and Seasonal Influenza
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Table 1.  Demographic Information of Patients With Swine-Origin and Seasonal Influenza From the Qazvin Province During the 2009 
Pandemic a
Risk factor Novel Influenza A (H1N1) Seasonal Influenza P Value
Age (< 18) 48/76 (63.2) 32/36 (88.9) 0.005
Gender (male) 45/76 (59.2) 22/36 (61.1) 0.848
Human contact 8/76 (10.5) 1/36 (2.8) 0.149
International travel 3/76 (3.9) 0/36 (0) 0.308
a  No/total (%).
Table 2.  Clinical Manifestations of Swine-Origin and Seasonal Influenza a
Clinical Manifestations Novel Influenza A (H1N1) Seasonal Influenza P Value
Fever 70/76 (92.1) 33/36 (91.7) 0.599
Cough 73/76 (96.0) 33/36 (91.7) 0.293
Myalgia 44/76 (57.9) 14/36 (38.9) 0.060
Gastro intestinal manifestations 26/76 (34.2) 2/36 (5.5) 0.001
a  No/total (%)
Table 3.  Course and Outcome of Swine-Origin and Seasonal Influenza a
Outcome Variables Novel Influenza A (H1N1) Seasonal Influenza P Value
Hospital admission 62/76 (81.6) 32/36 (88.9) 0.325
Admission in ICUs 12/76 (15.8) 7/36 (19.4) 0.630
Need for assisted ventilation 11/76 (14.5) 5/36 (13.9) 0.934
Mortality 2/76 (2.6) 1/36 (2.8) 0.691
a  No/total (%).
5. Discussion
One of the characteristics of the swine-origin influenza 
A (H1N1) pandemic was its rapid distribution worldwide, 
so that only after several months following the report of 
the first cases of the disease in early 2009, in the second 
half of the year, the most reported global cases of influen-
za were due to this virus; in Europe and United States this 
virus was isolated in more than 99% of influenza cases (5). 
In the present study, most confirmed cases of influenza 
were also associated with swine-origin H1N1 virus; prior 
to the beginning of the influenza season (until autumn 
2009), all confirmed cases of influenza and 68% of cases 
during the entire course of the study were due to the 
swine-origin influenza A (H1N1) virus. Another notewor-
thy epidemiological feature of pandemic influenza was 
the younger age of the patients. As it is evident, in the 
present study, the age of patients with swine-origin influ-
enza A (H1N1) was significantly lower than those with sea-
sonal flu. In studies carried out elsewhere, similar results 
have been reported; in some studies published at the 
beginning of the epidemic in developed countries, 60% 
of patients were 18 years old or younger (2). To elucidate 
this phenomenon, in addition to prior immunity in older 
individuals, the higher rate of sampling in the age group 
younger than 18 years (due to appearance of epidemic in 
schools) is propounded (6). Considering the antigenic 
similarities between swine-origin influenza A (H1N1) 
virus and viruses associated with influenza pandemics 
over the distant years, a group of American researchers 
attempted to perform a serological investigation for de-
tection of cross-reactive antibodies against swine-origin 
H1N1 virus on stored serum samples from many years 
ago. The results of this study showed that there was a 
clear difference in antibody titers between the sera of 
people born before 1950 and those after 1950; the titer 
of these antibodies was 34% in people born prior to 1950 
and 4% in those after 1980 (7). As shown in Figure 1, the 
epidemiological curve is indicative of a person-to-person 
transmission during the epidemic. The major routes for 
transmission were contact with fomites contaminat-
ed with respiratory or gastrointestinal secretions and 
through droplets produced during talking, sneezing and 
coughing (8, 9). As evident by the epidemiological curve, 
the highest number of seasonal influenza occurred dur-
ing November to December yet pandemic influenza took 
place in two waves. The first wave appeared from July 
to October and was mostly found in patients who had 
returned from Saudi Arabia whereas the second wave 
emerged after commencement of schools in September. 
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In the current study no history of traveling abroad in 
patients with seasonal flu was observed whereas three 
cases with novel influenza A (H1N1) had a history of travel 
to Saudi Arabia and all were infected during July to Au-
gust 2009. Saudi Arabia had reported the highest num-
ber of cases of swine-origin influenza A (H1N1) in the 
Eastern Mediterranean region until 2009 (10). Further-
more, while investigating the imported cases of disease 
in Iran until November 2009, the highest number was 
associated with the pilgrims who had come back from 
the eastern Mediterranean region. Babak et al report that 
52.2% of imported cases from the Isfahan province were 
travelers returning from Saudi Arabia (11). Although the 
symptoms of swine-origin influenza A (H1N1) were to a 
great extent similar to those of seasonal flu in the recent 
years, (12) gastrointestinal manifestations, were signifi-
cantly more prevalent in pandemic influenza in the pres-
ent study. This is a new feature in flu syndromes, as only 
13.4% of medical students in a cross-sectional research 
in Karachi, Pakistan reported nausea and vomiting as a 
symptom of swine-origin influenza A (H1N1) (13). More-
over, as reported by other studies, a higher incidence of 
myalgia (and even cases of rhabdomyolysis) among pa-
tients with swine-origin influenza (14) was also observed 
in the present study yet this difference was not statistical-
ly significant. In other studies carried out in Iran, higher 
prevalence of myalgia and diarrhea was reported as well. 
Saleh et al. reported as high as 80% prevalence for myalgia 
and 77.5% for diarrhea in 40 patients from the north west 
of Iran (15). In spite of initial reports of the high mortal-
ity rate in swine-origin influenza (38% of hospitalized 
patients in Mexico) (16), the later studies reported a mor-
tality rate for swine-origin influenza comparable with fig-
ures found for seasonal influenza. For instance, in a study 
by Louie et al. a mortality rate of 11% in hospitalized pa-
tients was reported (17). Even in the study of Cao et al. on 
426 confirmed cases of swine-origin influenza A (H1N1), 
admitted to 20 hospitals of China, no mortality was re-
ported (18). Also in another study by Chang et al. from 
Australia, there was no significant difference in admis-
sion to intensive care units, need for assisted ventilation, 
and mortality rate between patients with swine-origin 
influenza and those with seasonal flu (19). As mentioned 
in the results section, no difference in admission to inten-
sive care units, need for assisted ventilation and mortal-
ity rate was found between patients with swine-origin 
influenza A (H1N1) infection and those with seasonal flu. 
Comparison of swine-origin and seasonal influenza has 
not been studied in the Eastern Mediterranean region 
yet the mortality rate for swine-origin influenza has been 
reported for some territories. A mortality rate of 16.7% in 
Isfahan, (20) 20% in eastern Azerbaijan (15) and 15% for the 
pediatric age group in Zahedan (21) has reported. Torun 
et al. reported 14% intubation rate in 114 suspected swine-
origin influenza A (H1N1) patients in Turkey, who were 
amongst the pediatric age group. Fortunately, all patients 
survived in that study (22). 
There is only one study comparing swine-origin influen-
za A (H1N1) with other upper respiratory infection cases 
(not necessarily seasonal influenza) in Iran, which was 
conducted in the Hamadan province. In that study, mor-
tality in the former group was 3%, yet none of the patients 
in later group died. In that study other outcome variables 
(admission to intensive care units or need to assisted ven-
tilation) were not considered and no significant statisti-
cal difference in clinical presentation was found between 
swine-origin influenza A (H1N1) and other upper respira-
tory tract infections (23). Considering the occurrence of 
swine-origin H1N1 infection in younger age groups, the 
appearance of cases of disease outside the epidemic sea-
son, and the association of gastrointestinal symptoms 
with swine-origin H1N1 infection compared to seasonal 
flu, accurate attention to these criteria could boost the 
clinical suspicion of cases of novel influenza in the ab-
sence of sufficient diagnostic laboratory facilities. 
5.1. Limitations
This study was limited to the Qazvin province, situated 
in the North-West of Iran, in the Eastern Mediterranean 
region. The relatively low number of cases did not per-
mit us to analyze fatalities in specific populations such 
as pregnant women and overweigh patients. Performing 
similar research in different regions of the Middle East 
could produce more useful information related to dif-
ferences in underlying factors, clinical manifestations, 
course of disease and prognosis.
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